Literature DB >> 1362060

An association between a Bc1I restriction fragment length polymorphism of the glucocorticoid receptor locus and hyperinsulinaemia in obese women.

J U Weaver1, G A Hitman, P G Kopelman.   

Abstract

Obesity is likely to be a multifactorial disease with an important genetic component. Animal models of genetic and experimentally induced obesity suggest that glucocorticoid receptor (GR) activity plays a role in the aetiology and maintenance of the obese state. Glucocorticoid activity appears to be essential for the development of hyperinsulinaemia and subsequent fat deposition. In humans, glucocorticoid excess is associated with central fat distribution. We have therefore investigated the restriction fragment length polymorphisms of the human GR gene locus (GRL) and have sought associations of specific alleles with anthropometric measurements and indices of insulin secretion and resistance in obesity. Fifty-six extremely obese, unrelated, nondiabetic premenopausal British Caucasian females and 43 age-matched, normal weight controls were studied. The obese subjects were characterized by fat distribution (waist to hip ratio), insulin secretion and insulin resistance (fasting insulin (FI)), an index of insulin resistance (HOMA), stimulated insulin secretion during an oral glucose tolerance test and insulin-mediated glucose disposal, steady-state plasma glucose). A Bc1I polymorphism (fragments of 4.5 and 2.3 kb) demonstrated significant association with indices of glucose metabolism in obesity; those subjects homozygous for the 4.5 kb fragment had elevated FI (Pc = 0.012) and HOMA (Pc = 0.012) values. The genotypic and allelic frequencies of the GRL Bc1I polymorphism were otherwise similar in obese and normal weight subjects. We postulate that the GRL Bc1I polymorphism may directly affect GR gene expression, or be in linkage disequilibrium with a possible mutation within one of three exons of the GR gene, and thereby modulate GR transcriptional activity on target genes involved in glucose and insulin homeostasis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1362060     DOI: 10.1677/jme.0.0090295

Source DB:  PubMed          Journal:  J Mol Endocrinol        ISSN: 0952-5041            Impact factor:   5.098


  28 in total

Review 1.  Obesity and hypertension.

Authors:  E Faloia; G Giacchetti; F Mantero
Journal:  J Endocrinol Invest       Date:  2000-01       Impact factor: 4.256

Review 2.  Pharmacogenetics of antipsychotic-induced weight gain.

Authors:  Christoph U Correll; Anil K Malhotra
Journal:  Psychopharmacology (Berl)       Date:  2004-07-08       Impact factor: 4.530

Review 3.  Corticosteroid receptor genetic polymorphisms and stress responsivity.

Authors:  Roel DeRijk; E Ronald de Kloet
Journal:  Endocrine       Date:  2005-12       Impact factor: 3.633

4.  Glucocorticoid receptor polymorphisms in inflammatory bowel disease.

Authors:  G Decorti; S De Iudicibus; G Stocco; S Martelossi; I Drigo; F Bartoli; A Ventura
Journal:  Gut       Date:  2006-07       Impact factor: 23.059

Review 5.  Glucocorticoid signaling in the cell. Expanding clinical implications to complex human behavioral and somatic disorders.

Authors:  George P Chrousos; Tomoshige Kino
Journal:  Ann N Y Acad Sci       Date:  2009-10       Impact factor: 5.691

6.  The modulation of glucocorticoid receptor content by 3-O-methyl-D-glucose transport in human mononuclear leukocyte in obesity.

Authors:  M Güven; H Hatemi; E Taşan; Y Altuntaş; T Ulutin; V Tezcan; G Kanigür-Sultuybek
Journal:  J Endocrinol Invest       Date:  1998-11       Impact factor: 4.256

7.  A novel point mutation in the amino terminal domain of the human glucocorticoid receptor (hGR) gene enhancing hGR-mediated gene expression.

Authors:  Evangelia Charmandari; Takamasa Ichijo; William Jubiz; Smita Baid; Keith Zachman; George P Chrousos; Tomoshige Kino
Journal:  J Clin Endocrinol Metab       Date:  2008-09-30       Impact factor: 5.958

8.  Inhibiting endogenous cortisol blunts the meal-entrained rise in serum leptin.

Authors:  Blandine Laferrère; Cynthia Abraham; Marianne Awad; Stephanie Jean-Baptiste; Allison B Hart; Pilar Garcia-Lorda; Peter Kokkoris; Colleen D Russell
Journal:  J Clin Endocrinol Metab       Date:  2006-03-14       Impact factor: 5.958

9.  Impact of glucocorticoid receptor gene (NR3C1) polymorphisms in Turkish patients with metabolic syndrome.

Authors:  Z Kaya; S Caglayan; M Akkiprik; C Aral; G Ozisik; M Ozata; A Ozer
Journal:  J Endocrinol Invest       Date:  2015-11-23       Impact factor: 4.256

10.  The glucocorticoid receptor gene polymorphism N363S predisposes to more severe toxic side effects during pediatric acute lymphoblastic leukemia (ALL) therapy.

Authors:  O T Eipel; K Németh; D Török; K Csordás; M Hegyi; A Ponyi; A Ferenczy; D J Erdélyi; M Csóka; G T Kovács
Journal:  Int J Hematol       Date:  2013-01-26       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.